North China Pharmaceutical Co (SHSE:600812) Accounts Payable & Accrued Expense : ¥3,241 Mil (As of Mar. 2025)

View and export this data going back to 1994. Start your Free Trial

What is North China Pharmaceutical Co Accounts Payable & Accrued Expense?

North China Pharmaceutical Co's quarterly accounts payable & accrued expense declined from Sep. 2024 (¥3,252 Mil) to Dec. 2024 (¥2,915 Mil) but then increased from Dec. 2024 (¥2,915 Mil) to Mar. 2025 (¥3,241 Mil).

North China Pharmaceutical Co's annual accounts payable & accrued expense declined from Dec. 2022 (¥3,593 Mil) to Dec. 2023 (¥3,186 Mil) and declined from Dec. 2023 (¥3,186 Mil) to Dec. 2024 (¥2,915 Mil).

North China Pharmaceutical Co Accounts Payable & Accrued Expense Historical Data

The historical data trend for North China Pharmaceutical Co's Accounts Payable & Accrued Expense can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

North China Pharmaceutical Co Accounts Payable & Accrued Expense Chart

North China Pharmaceutical Co Annual Data

Trend

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Dec24

Accounts Payable & Accrued Expense

Get a 7-Day Free Trial

3,293.85

3,826.58

3,592.83

3,185.88

2,915.15

North China Pharmaceutical Co Quarterly Data
	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24	Dec24	Mar25
Accounts Payable & Accrued Expense	Get a 7-Day Free Trial															3,279.23	3,431.59	3,252.17	2,915.15	3,241.15

North China Pharmaceutical Co Accounts Payable & Accrued Expense Calculation

Accounts payable & accrued expense usually includes accounts payable, accrued compensation and related benefits, etc.

Accounts payable is money owed by a business to its suppliers shown as a liability on a company's balance sheet. It is distinct from notes payable liabilities, which are debts created by formal legal instrument documents.

It is part of the current portion of the liabilities (due within one year or within the normal operating cycle if longer) reflected on the balace sheet of the company. A higher Accounts Payable means lower Working Capital needed to operate the business.

North China Pharmaceutical Co Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » North China Pharmaceutical Co Ltd (SHSE:600812) » Definitions » Accounts Payable & Accrued Expense

Traded in Other Exchanges

N/A

Address

No. 388 Heping East Road, Shijiazhuang, Hebei, CHN, 050015

Website

http://www.ncpc.com

North China Pharmaceutical Co Ltd is engaged in the manufacture and sale of antibiotics, vitamins, and pharmaceutical products in China. The main products include antibiotics such as penicillin, vitamins, cephalosporins, streptomycin, biotechnological drugs, new preparations, and biological products.

Executives

Lv Wei	Supervisors
Gao Ren Long	senior management
Lian Fa Zhe	Director

North China Pharmaceutical Co Headlines

No Headlines